Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr 29:12:682195.
doi: 10.3389/fimmu.2021.682195. eCollection 2021.

Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment

Affiliations
Comment

Commentary: Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment

Juliana Lott Carvalho et al. Front Immunol. .
No abstract available

Keywords: COVID-19; SARS-CoV-2; advanced therapies; exosomes; stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Similar articles

References

    1. Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, et al. . Scoring Systems for Predicting Mortality for Severe Patients With COVID-19. EClinicalMedicine (2020) 24:100426. 10.1016/j.eclinm.2020.100426 - DOI - PMC - PubMed
    1. Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. . An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Nat Med (2020) 26:1636–43. 10.1038/s41591-020-1051-9 - DOI - PMC - PubMed
    1. Schäfer R, Spohn G, Bechtel M, Bojkova D, Baer PC, Kuçi S, et al. . Human Mesenchymal Stromal Cells are Resistant to SARS-CoV-2 Infection Under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells. Stem Cell Rep (2020) 16(3):419–27. 10.1016/j.stemcr.2020.09.003 - DOI - PMC - PubMed
    1. Saldanha-Araujo F, Melgaço Garcez E, Silva-Carvalho AE, Carvalho JL. Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment. Front Immunol (2020) 11:1563. 10.3389/fimmu.2020.01563 - DOI - PMC - PubMed
    1. Sengupta V, Sengupta S, Lazo A, Woods P, Nolan A, Bremer N. Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev (2020) 29:747–54. 10.1089/scd.2020.0080 - DOI - PMC - PubMed

Publication types

LinkOut - more resources